Paxlovid

Description

Product Description

Paxlovid is an FDA-approved oral antiviral medication developed by Pfizer to treat mild-to-moderate COVID-19 in adults and children (12+ years, ≥40 kg) at high risk of progressing to severe illness. Each treatment pack contains:

• Nirmatrelvir 150 mg (2 tablets per dose) – inhibits SARS-CoV-2 protease
• Ritonavir 100 mg (1 tablet per dose) – slows breakdown of nirmatrelvir

Paxlovid is most effective when started within 5 days of symptom onset.

Key Benefits

• Reduces risk of hospitalization and death
• Effective against multiple COVID-19 variants
• Convenient oral tablet form – no injections
• Short 5-day treatment course

How to Use

• Dosage: 2 Nirmatrelvir tablets + 1 Ritonavir tablet twice daily for 5 days
• Start treatment as soon as possible after diagnosis
• Swallow tablets whole, with or without food

Precautions

• Do not use with medications that interact with Ritonavir
• Not for patients with severe kidney or liver disease
• Consult a doctor before use if pregnant, breastfeeding, or immunocompromised

Possible Side Effects

• Altered or metallic taste
• Diarrhea
• High blood pressure
• Muscle pain
• Rare: Allergic reactions

FAQs

Q1. What is Paxlovid used for?
It is used to treat mild-to-moderate COVID-19 in high-risk patients, reducing the chance of severe illness.

Q2. Can Paxlovid cure COVID-19?
No. It does not cure the virus but prevents it from worsening in the body.

Q3. How quickly should Paxlovid be taken?
Begin within 5 days of symptoms for maximum effectiveness.

Q4. Can vaccinated individuals use Paxlovid?
Yes, especially if they are in a high-risk category.